Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1998-7-10
|
pubmed:abstractText |
The effects of intracerebral administration of the group II metabotropic glutamate receptor agonist, 2R,4R-APDC, were tested on both the development of amygdaloid kindling and on fully developed stage 5 amygdala kindled seizures. The development of amygdaloid kindling was significantly retarded in 2R,4R-APDC (10 nmol in 0.5 microl) treated animals compared to control animals over a period of 8 days. At a low dose, 2R,4R-APDC (0.1 nmol) caused a 42.5+/-26.6% increase of the generalised seizure threshold in fully kindled animals. As higher doses were administered, however, the changes in generalised seizure threshold were less marked, and even a small decrease in the threshold was seen (-19.6+/-5.36% at 10 nmol). The agonist 2R,4R-APDC inhibited depolarization-induced release of [3H]d-aspartate from cortical synaptosomes with an IC50 value of 0. 29 microM. This effect was maximal at 1 microM, and decreased with dose thereafter. These findings suggest that the selective activation of the group II metabotropic glutamate receptors by agonists such as 2R,4R-APDC may be of therapeutic potential in the treatment of seizure disorders.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anticonvulsants,
http://linkedlifedata.com/resource/pubmed/chemical/Excitatory Amino Acid Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Glutamic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Monosaccharide Transport Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proline,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Metabotropic Glutamate
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0006-8993
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 1998 Elsevier Science B.V.
|
pubmed:issnType |
Print
|
pubmed:day |
23
|
pubmed:volume |
787
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
286-91
|
pubmed:dateRevised |
2009-9-29
|
pubmed:meshHeading |
pubmed-meshheading:9518652-Animals,
pubmed-meshheading:9518652-Anticonvulsants,
pubmed-meshheading:9518652-Brain,
pubmed-meshheading:9518652-Dose-Response Relationship, Drug,
pubmed-meshheading:9518652-Epilepsy,
pubmed-meshheading:9518652-Excitatory Amino Acid Agonists,
pubmed-meshheading:9518652-Glutamic Acid,
pubmed-meshheading:9518652-Kindling, Neurologic,
pubmed-meshheading:9518652-Male,
pubmed-meshheading:9518652-Monosaccharide Transport Proteins,
pubmed-meshheading:9518652-Proline,
pubmed-meshheading:9518652-Rats,
pubmed-meshheading:9518652-Rats, Sprague-Dawley,
pubmed-meshheading:9518652-Receptors, Metabotropic Glutamate,
pubmed-meshheading:9518652-Synaptosomes
|
pubmed:year |
1998
|
pubmed:articleTitle |
Specific group II metabotropic glutamate receptor activation inhibits the development of kindled epilepsy in rats.
|
pubmed:affiliation |
Department of Biochemistry, Imperial College of Science, Technology and Medicine, London SW7 2AZ, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|